National Cancer Institute in Sabrata Treats 27,000 Patients in First Half of 2026

The Tripoli-based Libyan government has released operational statistics for the National Cancer Institute in Sabrata, revealing that it treated 27,570 outpatients during the first half of 2026. This initiative is part of a broader government program aimed at decentralizing and localizing medical treatment within Libya.

In addition to outpatient services, the institute reported significant activity in its diagnostic departments. Over 32,000 laboratory tests were performed, and nearly 10,000 radiological examinations were conducted. The institute also administered more than 9,600 chemotherapy and radiotherapy sessions, underscoring its role in providing critical cancer care.

The figures highlight the institute's capacity and the government's commitment to enhancing healthcare services domestically, reducing the need for citizens to seek treatment abroad. The focus on Sabrata's institute is part of a larger strategy to bolster healthcare infrastructure across the nation.